compound 33a（Oregon Health and Science University）

N/A

Report date: 2022/08/10 16:34:38
NME

Base Information

Drug Namecompound 33a（Oregon Health and Science University）
Drug Alias Name化合物33a（俄勒冈健康与科学大学）
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBcr-Abl tyrosine kinase inhibitors
TargetsBcr-Abl tyrosine kinase
Therapy Area/IndicationsLeukemia, Myelogenous, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOregon Health & Science University
China Registration ClassN/A

Develop Information

Active CompaniesOregon Health & Science University
Inactive CompaniesN/A
Active IndicationsLeukemia, Myelogenous, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A